Acute Leukemia — Trials

Acute Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

4,653 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,259
Recruiting: 759
Ph III recruiting: 70
Growth YoY: 0%
Industry share: 16%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 36.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (718)

clinicaltrialsPublishedShowing 101–150 of 345 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06364423	Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias	recruiting	Phase 1 / Phase 2	132	National Cancer Institute (NCI)NIH	1	Jul 16, 2026	clinicaltrials
NCT06533748	Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma	recruiting	Phase 2	128	St. Jude Children's Research HospitalOTHER	1	Jul 16, 2026	clinicaltrials